Recombinant Human ASPHD1 Protein，His

The study of ASPHD1 (aspartate beta-hydroxylase domain-containing protein 1) recombinant protein is rooted in its potential implications for various biological processes and disorders. ASPHD1 is an enzyme involved in the hydroxylation of aspartate residues in proteins, a modification that can influence protein stability, function, and interactions. This makes it a critical component in post-translational modifications, which are essential for proper cellular functioning. Recent research has indicated that dysregulation of such enzymes could be linked to various diseases, including certain cancers and metabolic disorders. Thus, understanding the structure and function of ASPHD1 is vital for elucidating its role in these pathological conditions. The recombinant expression of ASPHD1 allows for the production of large quantities of the protein, facilitating in vitro studies that can reveal its enzymatic activity, substrate specificity, and potential regulatory mechanisms. Such investigations could further elucidate the biological pathways in which ASPHD1 is involved, paving the way for novel therapeutic strategies that target its function. The recombinant protein also serves as a valuable tool for the development of assays that can screen for inhibitors or modulators of its activity, potentially leading to breakthroughs in the treatment of diseases associated with ASPHD1 dysregulation. Consequently, the exploration of ASPHD1 recombinant protein holds significant promise for advancing our understanding of fundamental biological processes and improving clinical outcomes in related disorders.